CoChat

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index; 13 of the 34 sources its claims cite were checked for support.

Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

Open access

Abstract

Diversity of the gut microbiome is associated with higher response rates for cancer patients receiving immunotherapy but has not been investigated in patients receiving radiation therapy. Additionally, current studies investigating the gut microbiome and outcomes in cancer patients may not have adjusted for established risk factors. Here, we sought to determine if diversity and composition of the gut microbiome was independently associated with survival in cervical cancer patients receiving chemoradiation. Our study demonstrates that the diversity of gut microbiota is associated with a favorable response to chemoradiation. Additionally, compositional variation among patients correlated with short term and long-term survival. Short term survivor fecal samples were significantly enriched in Porphyromonas , Porphyromonadaceae , and Dialister , whereas long term survivor samples were significantly enriched in Escherichia Shigella, Enterobacteriaceae , and Enterobacteriales . Moreover, analysis of immune cells from cervical tumor brush samples by flow cytometry revealed that patients with a high microbiome diversity had increased tumor infiltration of CD4+ lymphocytes as well as activated subsets of CD4 cells expressing ki67+ and CD69+ over the course of radiation therapy. Modulation of the gut microbiota before chemoradiation might provide an alternative way to enhance treatment efficacy and improve treatment outcomes in cervical cancer patients.

Overview

CoChat Summary

TL;DR

In a prospective cohort of 55 cervical cancer patients receiving definitive chemoradiation, baseline gut microbiome diversity was independently associated with recurrence-free and overall survival after adjusting for BMI. Higher diversity also correlated with increased tumor infiltration of activated CD4+ T-cell subsets.

Key findings

  • Baseline Shannon diversity index (SDI) was an independent predictor of recurrence-free survival (multivariate HR 0.36, 95% CI 0.15–0.84, P = 0.018) and overall survival (multivariate HR 0.19, 95% CI 0.043–0.83, P = 0.028); BMI was also independently prognostic for RFS (HR 0.87, 95% CI 0.77–0.98, P = 0.02) and OS (HR 0.78, 95% CI 0.623–0.97, P = 0.025).
  • During median follow-up of 24.5 months, 7 patients died (12.7%). Median RFS was 44 months for low baseline alpha diversity versus not reached for high diversity (P = 0.16); median OS was 48 months versus not reached (P = 0.094). Patients with normal BMI and higher SDI had longer median RFS (P = 0.0023) and OS (P = 0.19).
  • Short-term survivor fecal samples were enriched in Porphyromonas, Porphyromonadaceae, and Dialister, whereas long-term survivor samples were enriched in Escherichia Shigella, Enterobacteriaceae, and Enterobacteriales (P < 0.05; LDA score > 3.5). Low baseline Veillonella was associated with median OS of 48 months versus not reached for high abundance (P = 0.054).
  • High SDI correlated with tumor infiltration of CD4+ CD69+ and CD4+ PD1+ T cells at week 3 and CD4+ ki67+ T cells at week 5 (P = 0.004, Q = 0.14; P = 0.036, Q = 0.21; P = 0.004, Q = 0.07, respectively).

Methods

  • Prospective study of 55 patients with newly diagnosed locally advanced, nonmetastatic cervical carcinoma treated with definitive chemoradiation (external-beam radiotherapy plus weekly cisplatin followed by brachytherapy) at MD Anderson and Lyndon B. Johnson Hospital from 22 September 2015 to 11 January 2019. Rectal swabs were collected at baseline, weeks 1, 3, and 5 of radiotherapy, and 3 months after completion; cervical tumor brushings were collected before week 1 and at weeks 3 and 5 for flow cytometry.
  • 16S rRNA V4 sequencing was performed, with operational taxonomic units clustered at 97% similarity; alpha diversity was assessed by SDI and beta diversity by unweighted UniFrac principal coordinates analysis. An SDI cutoff of 2.69 was identified by ROC curve.
  • Survival analyses used univariate and multivariate Cox proportional hazards models for RFS and OS, with covariates at P ≤ 0.1 in univariate analysis entered into multivariate models; Kaplan–Meier curves and log-rank tests were used. Differential taxa were identified by LEfSe (P < 0.05; logarithmic LDA score > 3.5), and immune correlations used linear regression and Spearman correlation.

Limitations

  • The paper states that the small sample size limited statistical power; place of residence, lifestyle, and diet were not known; and racial variation could have impacted outcomes.
  • The text makes evident that several survival subgroup comparisons were not statistically significant (e.g., RFS P = 0.16 and OS P = 0.094 by high/low SDI), and immune correlation Q values were above 0.05 despite significant P values.
  • The study is observational and does not establish causality; the authors call for additional studies to understand the role of gut diversity in cervical cancer treatment.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s42003-021-01741-x

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Relationship between gut diversity and BMI. a Schema of the sample collection, treatment, and analyses used in the present study. Kaplan–Meier curves for b recurrence-free survival, c overall survival stratified by high and low gut diversity (SDI). Kaplan–Meier curves for d recurrence-free survival, e overall survival stratified by BMI and gut diversity. Cases represent patients. Only baseline samples were used for this analysis. BMI cutoffs were based on WHO standards (underweight < 18.5, normal 18.50–24.99, overweight ≥ 25, obese ≥ 30).
Fig. 1 Relationship between gut diversity and BMI. a Schema of the sample collection, treatment, and analyses used in the present study. Kaplan–Meier curves for b recurrence-free survival, c overall survival stratified by high and low gut diversity (SDI). Kaplan–Meier curves for d recurrence-free survival, e overall survival stratified by BMI and gut diversity. Cases represent patients. Only baseline samples were used for this analysis. BMI cutoffs were based on WHO standards (underweight < 18.5, normal 18.50–24.99, overweight ≥ 25, obese ≥ 30).CC BY · PubMed Central
Fig. 2 Compositional differences of the gut microbiome in short and long-term survivors. a The different abundance of bacterial taxa between the two groups were identified by LEfSe. It was significantly different when alpha value of the factorial Kruskal–Wallis test was <0.05 and the logarithmic LDA score was >3.5. The left histogram showed the LDA scores of taxa differentially abundant between the two groups. The taxonomy was listed, followed by its core group. Putative species (Specific OTUs) identified as significantly more enriched/depleted (Fisher/Wilcoxon test p value < 0.05) in patients with short-term vs long-term in baseline samples. b Cladogram representation of the significantly different taxa features from phylum (inner circle) to genus (outer circle). c The right heatmap showed the relative abundance of specific bacteria by phylum, class, order, family, and genus between short-term and long-term survivors.
Fig. 2 Compositional differences of the gut microbiome in short and long-term survivors. a The different abundance of bacterial taxa between the two groups were identified by LEfSe. It was significantly different when alpha value of the factorial Kruskal–Wallis test was <0.05 and the logarithmic LDA score was >3.5. The left histogram showed the LDA scores of taxa differentially abundant between the two groups. The taxonomy was listed, followed by its core group. Putative species (Specific OTUs) identified as significantly more enriched/depleted (Fisher/Wilcoxon test p value < 0.05) in patients with short-term vs long-term in baseline samples. b Cladogram representation of the significantly different taxa features from phylum (inner circle) to genus (outer circle). c The right heatmap showed the relative abundance of specific bacteria by phylum, class, order, family, and genus between short-term and long-term survivors.CC BY · PubMed Central
Fig. 3 Correlation analysis of Shannon Diversity Index with tumor immune signatures. a–d Spearman correlations between Shannon Diversity Index and CD4+, CD4+ Ki67+, CD4+ CD69+, and CD4+ PD1+. Statistical analysis was performed by Spearman correlation or Mann–Whitney tests.
Fig. 3 Correlation analysis of Shannon Diversity Index with tumor immune signatures. a–d Spearman correlations between Shannon Diversity Index and CD4+, CD4+ Ki67+, CD4+ CD69+, and CD4+ PD1+. Statistical analysis was performed by Spearman correlation or Mann–Whitney tests.CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 11 Not checked · 49 Own results and interpretations

28 more claims

Create a free account to see all 68 claims and to verify the 21 references still open.

See all claims — free account
  • Probably not a substantial claim. 25
  • It may state two separate claims as one. 17

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 61 references

Cited by

See all 135

Metadata

Authors
Sims, T. T., El Alam, M. B., Karpinets, T. V., Dorta-Estremera, S., Hegde, V. L., Nookala, S., Yoshida-Court, K., Wu, X., Biegert, G. W. G., Delgado Medrano, A. Y., Solley, T., Ahmed-Kaddar, M., Chapman, B. V., Sastry, K. J., Mezzari, M. P., Petrosino, J. F., Lin, L. L., Ramondetta, L., Jhingran, A., Schmeler, K. M., Ajami, N. J., Wargo, J., Colbert, L. E., & Klopp, A. H.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Baylor College of Medicine (US)
Corresponding author
  • Colbert, Lauren E.
  • Klopp, Ann H.
Venue
Communications Biology
Published
2021-02-22
Volume
4
Issue
1
Pages
237-237
ISSN
2399-3642 (ISSN-L)
OpenAlex
W3133213560
Cited by
135
References
60
Citations by year
2026: 17 · 2025: 31 · 2024: 25 · 2023: 24 · 2022: 24 · 2021: 13
FWCI
6.79
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • medRxiv (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Radiological Society of North America
  • Emerson Collective
  • National Institutes of Health (T32 grant)
  • University of Texas MD Anderson Cancer Center (CA101642, P30-CA-016672)
  • National Cancer Institute (P30CA016672, T32CA101642)
  • National Institute of Environmental Health Sciences (P30ES030285)
  • Moonshot Research and Development Program
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords
gut microbiota, microbiome diversity, cervical cancer, chemoradiotherapy, survival, treatment response, Porphyromonas, Dialister, Escherichia-Shigella, Enterobacteriaceae, tumor-infiltrating lymphocytes, CD4+ T cells, radiotherapy, microbiota modulation
MeSH terms
Gastrointestinal Microbiome, CD69 Antigens, Adult, Aged, Antigens, Differentiation, T-Lymphocyte, Uterine Cervical Neoplasms, Female, Humans, Intestines, Middle Aged, Prospective Studies, Time Factors, CD4-Positive T-Lymphocytes, Antigens, CD, Lymphocytes, Tumor-Infiltrating, Treatment Outcome, Ki-67 Antigen, Lectins, C-Type, Tumor Microenvironment, Chemoradiotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. https://app.cochat.ai/papers/10.1038/s42003-021-01741-x
The paper
Sims, T. T., El Alam, M. B., Karpinets, T. V., Dorta-Estremera, S., Hegde, V. L., Nookala, S., Yoshida-Court, K., Wu, X., Biegert, G. W. G., Delgado Medrano, A. Y., Solley, T., Ahmed-Kaddar, M., Chapman, B. V., Sastry, K. J., Mezzari, M. P., Petrosino, J. F., Lin, L. L., Ramondetta, L., Jhingran, A., . . . Klopp, A. H. (2021). Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Communications Biology. https://doi.org/10.1038/s42003-021-01741-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.